SAMN21490418
External Id
Joel Kralj, BioFrontiers, University of Colorado Boulder
INSDC center name
2022-12-31T00:00:00Z
INSDC first public
2022-12-31T05:29:39.590Z
INSDC last update
SRS10209742
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS10209742
SRA accession
Escherichia coli BW25113
http://purl.obolibrary.org/obo/NCBITaxon_679895
organism
Bacterial cells
source_name
0min
time point
30kan_t-0000_rep1
title
Kanamycin (30ug/mL)
treatment